Summary
Sensitivity to oestrogens and apoptosis are critical determinants of the development and progression of breast cancer and reflect closely linked pathways in breast epithelial cells. For example, induction of BCL-2 oncoprotein expression by oestrogen contributes to suppression of apoptosis and BCL-2 and oestrogen receptor (ER) are frequently co-expressed in tumours. BAG-1/HAP is a multifunctional protein which complexes with BCL-2 and steroid hormone receptors (including the ER), and can suppress apoptosis and influence steroid hormone-dependent transcription. Therefore, analysis of expression of BAG-1 in human breast cancer is of considerable interest. BAG-1 was readily detected by immunostaining in normal breast epithelial cells and most ER-positive tumours, but was undetectable or weakly expressed in ER-negative tumours. BAG-1 positive cells showed a predominantly cytoplasmic or cytoplasmic plus nuclear distribution of staining. A correlation between ER and BAG-1 was also evident in breast cancer derived cell lines, as all lines examined with functional ER expression also expressed high levels of BAG-1. In addition to the prototypical 36 kDa BAG-1 isoform, breast cancer cells expressed higher molecular weight isoforms and, in contrast to BCL-2, BAG-1 expression was independent of oestrogens. BAG-1 isoforms were differentially localized to the nucleus or cytoplasm and this was also independent of oestrogens. These results demonstrate a close association between BAG-1 and functional ER expression and suggest BAG-1 may be useful as a therapeutic target or prognostic marker in breast cancer.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Adachi, M, Masuo, S, Torigoe, T, Takayama, S, Reed, JC, Miyazaki, T, Minami, Y, Taniguchi, T & Imai, K (1996). Interleukin-2 (IL-2) upregulates Bag-1 gene expression through serine-rich region within IL-2 receptor βc chain. Blood 88: 4118–4123.
Bardelli, A, Longati, P, Albero, D, Goruppi, S, Schneider, A, Ponzetta, C & Comoglio, PM (1996). HGF receptor associates with the anti-apoptotic protein Bag-1 and prevents cell death. EMBO J 15: 6205–6212.
Bardon, S, Vignon, F, Montcourrier, P & Rochefort, H (1987). Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells. Cancer Res 47: 1441–1448.
Beveglia, L, Matsumoto, K, Lin, CS, Ziober, BL & Kramer, RH (1997). Expression of the c-Met/HGF receptor in human breast carcinoma; correlation with tumor progression. Int J Cancer 74: 301–309.
Bhargava, V, Kell, DL, van de Rijn, M & Warnke, RA (1994). Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol 145: 535–540.
Chalbos, D, Vignon, F, Keydar, I & Rochefort, H (1982). Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). J Clin Endocrinol Metab 55: 276–283.
Clarke, C, Titley, J, Davies, S & O’Hare, MJ (1994). An immunomagnetic separation method using supermagnetic (MACS) beads for large-scale purificiation of human mammary luminal and myoepithelial cells. Epithelial Cell Biol 3: 38–46.
Clevenger, CV, Thickman, K, Ngo, W, Chang, W-P, Takayama, S & Reed, JC (1997). Role of Bag-1 in the survival and proliferation of the cytokine-dependent lymphocyte lines, Ba/F3 and Nb2. Mol Endocrinol 11: 608–618.
Coradini, D, Cappelletti, V, Granta, G & di Fonzo, G (1991). Activity of tamoxifen and its metabolites on endocrine-dependent and endocrine-independent breast cancer cells. Tumour Biol 12: 149–158.
Engel, LW, Young, NA, Tralka, TS, Lippman, ME, O’Brien, SJ & Joyce, MJ (1978). Establishment and characterisation of three new continuous cell lines derived from human breast carcinomas. Cancer Res 38: 3352–3364.
Fredersdorf, S, Milne, AW, Hall, PA & Lu, X (1996). Characterisation of a panel of novel anti-p21waf1/cip1 monoclonal antibodies and immunochemical analysis of p21waf1/cip1 expression in normal human tissues. Am J Pathol 148: 825–835.
Froesch, BA, Takayama, S & Reed, JC (1998). Bag-1L protein enhances androgen receptor function. J Biol Chem 273: 11660–11666.
Gioanni, J, Le, FD, Zanghellini, E, Mazeau, C, Ettore, F, Lambert, JC, Schneider, M & Dutrillaux, B (1990). Establishment and characterisation of a new tumorigenic cell line with a normal karyotype derived from a human breast adenocarcinoma. Br J Cancer 62: 8–13.
Hohfeld, J & Jentsch, S (1997). GrpE-like regulation of the hsc70 chaperone by the anti-apoptotic protein Bag-1. EMBO J 16: 6209–6216.
Huang, Y, Ray, S, Reed, JC, Ibrado, AM, Tang, C, Nawabi, A & Bhalla, K (1997). Estrogen increases intracellular p26Bcl-2 to p21 Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells. Breast Cancer Res Treat 42: 73–81.
Hurst, J, Maniar, N, Tombarkiewicz, J, Lucas, F, Roberson, C, Steplewski, Z, James, W & Perras, J (1993). A novel model of a metastatic human breast tumour xenograft line. Br J Cancer 6: 274–276.
Kullmann, M, Schneikert, J, Moll, J, Heck, S, Zeiner, M, Gehring, U & Cato, ACB (1998). Rap46 is a negative regulator of glucocorticoid receptor action and hormone-induced apoptosis. J Biol Chem 273: 14620–14625.
Kyprianou, N, English, HF, Davidson, NE & Isaacs, JT (1991). Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 51: 162–166.
Landel, CC, Kushner, PJ & Greene, GL (1994). The interaction of human estrogen receptor with DNA is modulated by receptor associated proteins. Mol Endocrinol 8: 1407–1419.
Leek, RD, Kaklamanis, L, Pezzella, F, Gatter, KC & Harris, AL (1994). Bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 69: 135–139.
Lippman, ME & Dickson, RB (1989). Mechanisms of growth control in normal and malignant breast epithelium. Recent Prog 45: 383–440.
Lippman, ME, Bolan, G & Huff, K (1976). The effects of estrogens and anti-estrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36: 4595–4601.
Liu, R, Takayama, S, Zheng, Y, Froesch, B, Chen, G-Q, Zhang, X, Reed, JC & Zhang, X-K (1998). Interaction of BAG-1 with retinoic acid receptor and its inhibition of retinoic acid-induced apoptosis in cancer cells. J Biol Chem 273: 16985–16992.
Matsuzawa, S-I, Takayama, S, Froesch, BA, Zapata, JM & Reed, JC (1998). p53-inducible human homologue of drosophila seven in absentia (siah) inhibits cell growth: suppression by Bag-1. EMBO J 17: 2736–2747.
Packham, G, Brimmell, M & Cleveland, JL (1997). Mammalian cells express two differently localized BAG-1 isoforms generated by alternate translation. Biochem J 328: 807–813.
Reed, JC (1997). Double identity for proteins of the Bcl-2 family. Nature 387: 773–776.
Schulz, JB, Bremen, D, Reed, JC, Lommatzsch, J, Takayama, S, Wullner, U, Loschmann, PA, Klockgether, T & Weller, M (1997). Cooperative interception of neuronal apoptosis by bcl-2 and bag-1 expression; prevention of caspase activation and reduced production of reactive oxygen species. J Neurochem 69: 2075–2086.
Silvestrini, R, Veneroni, S, Daidone, MG, Benini, E, Boracchi, P, Mezzetti, M, di Fronzo, G, Rilke, F & Veronesi, U (1994). The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst 86: 499–504.
Takayama, S, Sato, T, Krajewski, S, Kochel, K, Irie, S, Millan, JA & Reed, JC (1995). Cloning and functional analysis of Bag-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 80: 279–284.
Takayama, S, Kochel, K, Irie, S, Inazawa, J, Abe, T, Sato, T, Druck, T, Huebner, K & Reed, JC (1996). Cloning of cDNAs encoding the human BAG1 protein and localisation of the human BAG1 gene to chromosome 9p12. Genomics 35: 494–498.
Takayama, S, Bimston, DN, Matsuzawa, S, Freeman, BC, Aime-Sempe, C, Xie, Z, Morimoto, RJ & Reed, JC (1997). Bag-1 modulates the chaperone activity of hsp70/hsc70. EMBO J 16: 4887–4896.
Takayama, S, Krajewski, S, Krajewski, M, Kitada, S, Zapata, JM, Kochel, K, Knee, D, Scudiero, D, Tudor, G, Miller, GJ, Miyashita, T, Yamada, M & Reed, JC (1998). Expression and location of HSP70/HSC-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res 58: 3116–3131.
Teixeira, C, Reed, JC & Pratt, MAC (1995). Estrogen promotes chemotherapeutic drug resistance by a mechanism involving bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res 55: 3902–3907.
Tuck, AB, Park, M, Sterns, EE, Boag, A & Elliott, BE (1996). Coexpression of hepatocyte growth factor and receptor (met) in human breast carcinoma. Am J Pathol 148: 225–232.
Wakeling, AE, Dukes, M & Bowler, J (1991). A potent specific pure antiestrogen with clinical potential. Cancer Res 51: 3867–3873.
Wang, HG, Takayama, S, Rapp, UR & Reed, JC (1996). Bcl-2 interacting protein, Bag-1, binds to and activates the kinase Raf-1. Proc Natl Acad Sci USA 93: 7063–7068.
Wilson, JW, Wakeling, AE, Morris, ID, Hickman, JA & Dive, C (1995). MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damage. Int J Cancer 61: 502–508.
Zapata, JM, Krajewska, M, Krajewska, S, Huang, R-P, Takayama, S, Wang, H-G, Adamson, E & Reed, JC (1998). Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumours. Breast Cancer Res Treat 47: 129–140.
Ziener, M & Gehring, U (1995). A protein that interacts with members of the nuclear hormone receptor family: identification and cDNA cloning. Proc Natl Acad Sci USA 92: 11465–11469.
Zeiner, M, Gebauer, M & Gehring, U (1997). Mammalian protein RAP46: an interaction partner and modulator of 70 kDa heat shock proteins. EMBO J 167: 5483–5490.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Brimmell, M., Burns, J., Munson, P. et al. High level expression of differentially localized BAG-1 isoforms in some oestrogen receptor-positive human breast cancers. Br J Cancer 81, 1042–1051 (1999). https://doi.org/10.1038/sj.bjc.6690805
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690805
Keywords
This article is cited by
-
Interaction between the BAG1S isoform and HSP70 mediates the stability of anti-apoptotic proteins and the survival of osteosarcoma cells expressing oncogenic MYC
BMC Cancer (2019)
-
BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses
British Journal of Cancer (2017)
-
The Bag-1 inhibitor, Thio-2, reverses an atypical 3D morphology driven by Bag-1L overexpression in a MCF-10A model of ductal carcinoma in situ
Oncogenesis (2016)
-
Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosis
BMC Cancer (2013)
-
BAG-1 suppresses expression of the key regulatory cytokine transforming growth factor β (TGF-β1) in colorectal tumour cells
Oncogene (2013)